Last reviewed · How we verify
NCT06941506
Using SPOZ Technology to Support and Enhance the Vitality Acupunch (VA) Exercise Program for Older Adults With Dementia
NA trial testing VA-SPOZ exercise program in Cognitive and Behavioral Impairment in 142 participants. Completed in 18 December 2025.
18 December 2025
Quick facts
| Lead sponsor | Kaohsiung Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 142 |
| Start date | 23 April 2025 |
| Primary completion | 18 December 2025 |
| Estimated completion | 18 December 2025 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- VA-SPOZ exercise program
- Control
Conditions studied
- Cognitive and Behavioral Impairment — all drugs for Cognitive and Behavioral Impairment →
- Sensory and Perceptual Impairment — all drugs for Sensory and Perceptual Impairment →
Sponsor
Kaohsiung Medical University
Who can join
Adults 65 to 100, any sex, with Cognitive and Behavioral Impairment or Sensory and Perceptual Impairment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project was aimed to examine the effects of a six-month VA exercise program incorporate the SPOZ technology in improving the cognitive behavioral impairment and sensory perceptual impairment of older adults with dementia in adult daycare centers.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06941506
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of VA-SPOZ exercise program
Trials testing the same drug.
- NCT06942832 — Integrating SPOZ Technology to Support and Enhance the Vitality Acupunch (VA) Exercise Program for Older Adults With Dem · NA · completed
Other recruiting trials for Cognitive and Behavioral Impairment
Currently open trials in the same condition.
- NCT07338682 — Evaluation of the Effect of L-Arginine on the Cognitive Function in Geriatric Patients · Phase 2 · recruiting
- NCT07135336 — Incidence of Postoperative Cognitive Decline in Patients With Preexisting Cognitive Impairment · recruiting
Other Kaohsiung Medical University trials
Trials by the same sponsor.
- NCT07341620 — Effectiveness of an Online Interactive E-book in Enhancing Home Care Nurses' Knowledge, Perceived Barriers, and Self-eff · NA · recruiting
- NCT07297511 — Application of Multiple Vertical Jump Tests in Return-to-Play Assessment for Anterior Cruciate Ligament Reconstruction A · not yet recruiting
- NCT07337200 — The Effectiveness of Three Good Things on Gratitude and Psychological Well-being Among Nursing Students · NA · not yet recruiting
- NCT07375888 — The Application of an Innovative Reactive Agility Testing System for Assessment in Older Adults With Dynapenia · completed
- NCT07358130 — Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06941506 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kaohsiung Medical University
- Last refreshed: 24 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06941506.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing